Larvol Delta - CG-Oncology-Announces-Publication-of-Pivotal-Phase-3-BOND003-Cohort-C-Study-Results-in-The-Lancet-Oncology

cretostimogene grenadenorepvec (CG0070) - CG Oncology

https://www.globenewswire.com/news-release/2026/07/27/3333936/0/en/cg-oncology-announces-publication-of-pivotal-phase-3-bond-003-cohort-c-study-results-in-the-lancet-oncology.html

Jul 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next